Cationically modified inhalable nintedanib niosomes: enhancing therapeutic activity against non-small-cell lung cancer.

K Shukla, Snehal; Nguyen, Veronica; Goyal, Mimansa; Gupta, Vivek

K Shukla, Snehal; Nguyen, Veronica; Goyal, Mimansa; Gupta, Vivek.

Affiliation

K Shukla S; Department of Pharmaceutical Sciences, College of Pharmacy & Health Sciences, St. John's University, NY 11439, USA.
Nguyen V; Current Affiliation: Pfizer Worldwide R&D, Groton, CT 06340, USA.
Goyal M; Department of Pharmaceutical Sciences, College of Pharmacy & Health Sciences, St. John's University, NY 11439, USA.
Gupta V; Department of Pharmaceutical Sciences, College of Pharmacy & Health Sciences, St. John's University, NY 11439, USA.

Nanomedicine (Lond) ; 17(13): 935-958, 2022 06.

Article de En | MEDLINE | ID: mdl-36004583

Sujet(s)
Mots clés

aerosol; cationically modified vesicles; inhalable delivery carrier; nintedanib; niosomes; non-small-cell lung cancer; tyrosine kinase

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Carcinome pulmonaire non à petites cellules / Tumeurs du poumon Limites: Humans Langue: En Journal: Nanomedicine (Lond) Année: 2022 Type de document: Article Pays d'affiliation: États-Unis d'Amérique Pays de publication: Royaume-Uni

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google